Please use this identifier to cite or link to this item: https://doi.org/10.1128/AAC.01297-08
Title: High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia
Authors: Lee, H.-Y.
Su, L.-H.
Tsai, M.-H.
Kim, S.-W.
Chang, H.-H.
Jung, S.-I.
Park, K.-H.
Perera, J.
Carlos, C.
Ban, H.T.
Kumarasinghe, G.
So, T.
ChongthaLeong, A. 
Hsueh, P.-R.
Liu, J.-W.
Song, J.-H.
Chiu, C.-H.
Issue Date: Jun-2009
Citation: Lee, H.-Y., Su, L.-H., Tsai, M.-H., Kim, S.-W., Chang, H.-H., Jung, S.-I., Park, K.-H., Perera, J., Carlos, C., Ban, H.T., Kumarasinghe, G., So, T., ChongthaLeong, A., Hsueh, P.-R., Liu, J.-W., Song, J.-H., Chiu, C.-H. (2009-06). High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrobial Agents and Chemotherapy 53 (6) : 2696-2699. ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.01297-08
Abstract: This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Source Title: Antimicrobial Agents and Chemotherapy
URI: http://scholarbank.nus.edu.sg/handle/10635/133364
ISSN: 00664804
DOI: 10.1128/AAC.01297-08
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

68
checked on Oct 15, 2018

WEB OF SCIENCETM
Citations

63
checked on Oct 15, 2018

Page view(s)

16
checked on Jul 5, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.